| Today, Tue, Nov 24, 2009 | | | Icahn Makes Big Moves in Healthcare Stocks Indie Research (Tue 1:13AM)
| | Sat, Nov 21, 2009 | | | Wall Street's 10 Favorite Stocks Right Now at Motley Fool (Sat, Nov 21)
| | | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst Wall Street Transcript (Sat, Nov 21)
| | Fri, Nov 20, 2009 | | | Biotech Stock Mailbag: FDA Playbook at TheStreet.com (Fri, Nov 20)
| | | Now's a Great Time to Invest -- So Don't Blow It Like This at Motley Fool (Fri, Nov 20)
| | | This Stock Is a Train Wreck at Motley Fool (Fri, Nov 20)
| | | Genzyme: Analysts' Upgrades, Downgrades at TheStreet.com (Fri, Nov 20)
| | | Genzyme's Problems Continue Zacks.com (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | | Zacks #5 Rank Additions for Thursday Zacks.com (Thu, Nov 19)
| | | Drug Lowers Cholesterol; Stock Follows at Motley Fool (Thu, Nov 19)
| | | Genzyme Drops Kidney-Drug Plans Amid Pileup of Bad News at The Wall Street Journal Online (Thu, Nov 19)
| | | UPDATE - Genzyme negative news continues; stops drug trial at Reuters (Thu, Nov 19)
| | | Another Genzyme Drug Goes Kaboom: BioBuzz at TheStreet.com (Thu, Nov 19)
| | Wed, Nov 18, 2009 | | | [$$] Genzyme Ends Effort to Develop Stronger Version of Renvela at The Wall Street Journal Online (Wed, Nov 18)
| | | Genzyme ends development of Renvela successor AP (Wed, Nov 18)
| | | Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder Business Wire (Wed, Nov 18)
| | | GENZ's Lumizyme Approval Delayed Zacks.com (Wed, Nov 18)
| | | Bulls Speculate On Long Dowdy Duds at Forbes.com (Wed, Nov 18)
| | | Genzyme's Termeer: Worst Biotech CEO of '09 at TheStreet.com (Wed, Nov 18)
| | | UPDATE - Isis drug meets all study goals; filing delayed at Reuters (Wed, Nov 18)
| | Older Headlines | |
| |
|